Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update. 2012;18:525–35.
Article CAS PubMed Google Scholar
McLaughlin M, Kelsey TW, Wallace WHB, Anderson RA, Telfer EE. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary. Hum Reprod 2016.
Yin O, Cayton K, Segars JH. In Vitro activation: a dip into the primordial follicle Pool? J Clin Endocrinol Metabolism. 2016;101:3568–70.
Davis SR, Baber RJ. Treating menopause — MHT and beyond. Nat Reviews Endocrinol. 2022;18:490–502.
Vandermeulen M, Erpicum P, Weekers L, Briquet A, Lechanteur C, Detry O, Beguin Y, Jouret F. Mesenchymal stromal cells in solid organ transplantation. Transplantation. 2020;104:923–36.
Fazeli Z, Abedindo A, Omrani MD, Ghaderian SMH. Mesenchymal stem cells (MSCs) therapy for recovery of fertility: a systematic review. Stem Cell Reviews Rep. 2017;14:1–12.
Yoon SY, Yoon JA, Park M, Shin E-Y, Jung S, Lee JE, Eum JH, Song H, Lee DR, Lee WS. Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice. Stem Cell Res Ther 2020, 11.
Ai G, Meng M, Guo J, Li C, Zhu J, Liu L, Liu B, Yang W, Shao X, Cheng Z. Adipose-derived stem cells promote the repair of chemotherapy-induced premature ovarian failure by inhibiting granulosa cells apoptosis and senescence. Stem Cell Res Ther 2023, 14.
Deng T, He J, Yao Q, Wu L, Xue L, Wu M, Wu D, Li C, Li Y. Human umbilical cord mesenchymal stem cells improve ovarian function in Chemotherapy-Induced premature ovarian failure mice through inhibiting apoptosis and inflammation via a paracrine mechanism. Reprod Sci. 2021;28:1718–32.
Article CAS PubMed Google Scholar
Ding L, Yan G, Wang B, Xu L, Gu Y, Ru T, Cui X, Lei L, Liu J, Sheng X. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci. 2018;61:1554–65.
Article CAS PubMed Google Scholar
Shareghi-oskoue O, Aghebati-Maleki L, Yousefi M. Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure. Stem Cell Res Ther 2021, 12.
Yan L, Wu Y, Li L, Wu J, Zhao F, Gao Z, Liu W, Li T, Fan Y, Hao J, et al. Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency. Cell Prolif. 2020;53:e12938.
Article CAS PubMed PubMed Central Google Scholar
Lv X, Guan C, Li Y, Su X, Zhang L, Wang X, Xia HF, Ma X. Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice. J Ovarian Res. 2021;14:119.
Article CAS PubMed PubMed Central Google Scholar
Ding C, Zhu L, Shen H, Lu J, Zou Q, Huang C, Li H, Huang B. Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7. Stem Cells. 2020;38:1137–48.
Article CAS PubMed Google Scholar
Dixon Scott J, Lemberg Kathryn M, Lamprecht Michael R, Skouta R, Zaitsev Eleina M, Gleason Caroline E, Patel Darpan N, Bauer Andras J, Cantley Alexandra M, Yang Wan S. Ferroptosis: An Iron-Dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72.
Article CAS PubMed PubMed Central Google Scholar
Liu M, Wu K, Wu Y. The emerging role of ferroptosis in female reproductive disorders. Biomed Pharmacother. 2023;166:115415.
Article CAS PubMed Google Scholar
Wang F, Liu Y, Ni F, Jin J, Wu Y, Huang Y, Ye X, Shen X, Ying Y, Chen J. BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency. Nat Commun 2022, 13.
Wang R, Wang W, Wang L, Yuan L, Cheng F, Guan X, Zheng N, Yang X. FTO protects human granulosa cells from chemotherapy-induced cytotoxicity. Reproductive Biology Endocrinol 2022, 20.
Du R, Cheng X, Ji J, Lu Y, Xie Y, Wang W, Xu Y, Zhang Y. Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin. Sci Rep 2023, 13.
Zhang S, Liu Q, Chang M, Pan Y, Yahaya BH, Liu Y, Lin J. Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis. Cell Death Dis 2023, 14.
Wang S, Li X, Li J, Wang A, Li F, Hu H, Long T, Pei X, Li H, Zhong F. Inhibition of cisplatin-induced Acsl4-mediated ferroptosis alleviated ovarian injury. Chemico-Biol Interact. 2024;387:110825.
Huang X, Song Y, Wei L, Guo J, Xu W, Li M. The emerging roles of ferroptosis in organ fibrosis and its potential therapeutic effect. Int Immunopharmacol. 2023;116:109812.
Article CAS PubMed Google Scholar
Hu G, Cui Z, Chen X, Sun F, Li T, Li C, Zhang L, Guo X, Zhao H, Xia Y. Suppressing Mesenchymal Stromal Cell Ferroptosis Via targeting a metabolism-epigenetics Axis corrects their poor Retention and Insufficient Healing benefits in the injured liver milieu. Adv Sci 2023:2206439.
Pan R, Wang R, Cheng F, Wang L, Cui Z, She J, Yang X. Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression. Reprod Biol Endocrinol. 2024;22:41.
Article CAS PubMed PubMed Central Google Scholar
Dai W, Yang H, Xu B, He T, Liu L, Zhang Z, Ding L, Pei X, Fu X. 3D hUC-MSC spheroids exhibit superior resistance to autophagy and apoptosis of granulosa cells in POF rat model. Reproduction 2024, 168.
Zhou Y, Huang J, Zeng L, Yang Q, Bai F, Mai Q, Deng K. Human mesenchymal stem cells derived exosomes improve ovarian function in chemotherapy-induced premature ovarian insufficiency mice by inhibiting ferroptosis through Nrf2/GPX4 pathway. J Ovarian Res. 2024;17:80.
Article CAS PubMed PubMed Central Google Scholar
Weinhart M, Hocke A, Hippenstiel S, Kurreck J, Hedtrich S. 3D organ models—revolution in pharmacological research? Pharmacol Res. 2019;139:446–51.
Article CAS PubMed Google Scholar
Baker BM, Chen CS. Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues. J Cell Sci 2012.
Ghezelayagh Z, Khoshdel-Rad N, Ebrahimi B. Human ovarian tissue in-vitro culture: primordial follicle activation as a new strategy for female fertility preservation. Cytotechnology. 2022;74:1–15.
Article CAS PubMed PubMed Central Google Scholar
Xu W, Wu C, Zhu X, Wu J, Zhang Z, Wei Z, Cao Y, Zhou P, Wang J. UC-MSCs promote frozen-thawed ovaries angiogenesis via activation of the Wnt/β-catenin pathway in vitro ovarian culture system. Stem Cell Res Ther 2022, 13.
Scott JE, Carlsson IB, Bavister BD, Hovatta O. Human ovarian tissue cultures: extracellular matrix composition, coating density and tissue dimensions. Reprod Biomed Online. 2004;9:287–93.
Article CAS PubMed Google Scholar
Wang J, Hu R, Xing Q, Feng X, Jiang X, Xu Y, Wei Z. Exosomes derived from umbilical cord mesenchymal stem cells alleviate Mifepristone-Induced Human Endometrial Stromal Cell Injury. Stem Cells Int. 2020;2020:1–9.
Kim T-H, Choi JH, Jun Y, Lim SM, Park S, Paek J-Y, Lee S-H, Hwang J-Y, Kim GJ. 3D-cultured human placenta-derived mesenchymal stem cell spheroids enhance ovary function by inducing folliculogenesis. Sci Rep 2018, 8.
Szymanska KJ, Tan X, Oktay K. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging. Mol Hum Reprod. 2020;26:553–66.
Article CAS PubMed PubMed Central Google Scholar
Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, Klinger FG. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25:673–93.
Article CAS PubMed PubMed Central Google Scholar
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266–82.
Article PubMed PubMed Central Google Scholar
Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X, Wu C. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021;277:121110.
Article CAS PubMed Google Scholar
Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, Izumikawa T, Conrad M, Bannai S, Sato H. The ferroptosis inducer erastin irreversibly inhibits system x(c)- and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells. Sci Rep. 2018;8:968.
Article PubMed PubMed Central Google Scholar
Prasanna PG, Citrin DE, Hildesheim J, Ahmed MM, Venkatachalam S, Riscuta G, Xi D, Zheng G. Deursen Jv, Goronzy J: Therapy-Induced Senescence: opportunities to improve Anticancer Therapy. JNCI: J Natl Cancer Inst. 2021;113:1285–98.
Article PubMed PubMed Central Google Scholar
Sears SM, Siskind LJ. Potential therapeutic targets for Cisplatin-Induced kidney Injury: lessons from other models of AKI and Fibrosis. J Am Soc Nephrol. 2021;32:1559–67.
Article CAS PubMed PubMed Central Google Scholar
Li Z, Zhang M, Tian Y, Li Q, Huang X. Mesenchymal stem cells in premature ovarian insufficiency: mechanisms and prospects. Front Cell Dev Biology 2021, 9.
Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587:555–66.
留言 (0)